Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.33 USD
Change Today +0.002 / 0.61%
Volume 95.8K
RGDX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 5:20 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

response genetics inc (RGDX) Snapshot

Open
$0.34
Previous Close
$0.33
Day High
$0.35
Day Low
$0.33
52 Week High
06/24/14 - $1.11
52 Week Low
04/1/15 - $0.18
Market Cap
12.9M
Average Volume 10 Days
306.4K
EPS TTM
$-0.36
Shares Outstanding
38.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RESPONSE GENETICS INC (RGDX)

Related News

No related news articles were found.

response genetics inc (RGDX) Related Businessweek News

No Related Businessweek News Found

response genetics inc (RGDX) Details

Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

96 Employees
Last Reported Date: 03/31/15
Founded in 1999

response genetics inc (RGDX) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $767.9K
Chief Financial Officer
Total Annual Compensation: $327.6K
Compensation as of Fiscal Year 2014.

response genetics inc (RGDX) Key Developments

Response Genetics, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Response Genetics Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the period, the company’s net revenue was $3,790,604 against $3,894,934 a year ago. Operating loss was $3,640,902 against $3,477,812 a year ago. Net loss was $4,018,380 against $3,504,439 a year ago. Net loss per share — basic and diluted was $0.10 against $0.09 a year ago.

Response Genetics, Inc to Report Q1, 2015 Results on May 14, 2015

Response Genetics, Inc announced that they will report Q1, 2015 results at 10:00 AM, US Eastern Standard Time on May 14, 2015

Response Genetics, Inc, Q1 2015 Earnings Call, May 14, 2015

Response Genetics, Inc, Q1 2015 Earnings Call, May 14, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGDX:US $0.33 USD +0.002

RGDX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cancer Genetics Inc $11.29 USD +0.29
Psychemedics Corp $14.52 USD -0.29
Rosetta Genomics Ltd $3.66 USD +0.07
Signal Genetics Inc $1.55 USD -0.07
Veracyte Inc $11.13 USD +0.43
View Industry Companies
 

Industry Analysis

RGDX

Industry Average

Valuation RGDX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE GENETICS INC, please visit www.responsegenetics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.